1. Home
  2. PRTA vs RBB Comparison

PRTA vs RBB Comparison

Compare PRTA & RBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

N/A

Current Price

$8.15

Market Cap

429.2M

Sector

Health Care

ML Signal

N/A

Logo RBB Bancorp

RBB

RBB Bancorp

N/A

Current Price

$24.46

Market Cap

441.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PRTA
RBB
Founded
2012
2008
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
429.2M
441.7M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
PRTA
RBB
Price
$8.15
$24.46
Analyst Decision
Buy
Hold
Analyst Count
7
5
Target Price
$21.40
★ $28.90
AVG Volume (30 Days)
★ 420.1K
77.5K
Earning Date
11-05-2026
10-19-2026
Dividend Yield
N/A
★ 2.62%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 1.99
Revenue
$814,000.00
★ $5,167,000.00
Revenue This Year
$775.41
$4.95
Revenue Next Year
N/A
$2.10
P/E Ratio
★ N/A
$12.29
Revenue Growth
N/A
★ N/A
52 Week Low
$7.70
$19.13
52 Week High
$11.80
$28.24

Technical Indicators

Market Signals
Indicator
PRTA
RBB
Relative Strength Index (RSI) 45.82 30.14
Support Level $8.01 $22.85
Resistance Level $9.14 $24.72
Average True Range (ATR) 0.44 0.56
MACD -0.01 -0.16
Stochastic Oscillator 37.55 11.31

Price Performance

Historical Comparison
PRTA
RBB

About PRTA Prothena Corporation plc

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

About RBB RBB Bancorp

RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.

Share on Social Networks: